Bone Biologics receives Notice of Allowance of patent claims that protects formation of cartilage by UCB-1 (News-Medical-Net)

Bone Biologics, Inc. announced today that it has received a US Patent Office Notice of Allowance of patent claims which strongly protects the formation of cartilage by the unique NELL 1 protein (UCB-1). Additional claims cover the surgical application of the NELL 1 (UCB-1) protein by several delivery agents.